NEW YORK, NY, UNITED STATES, January 6, 2026 / EINPresswire.com / — Panther Life Sciences announces expanded access to its ...
The global DNA methylation market size was valued at US$ 1.9 Bn in 2025 and is projected to reach US$ 7.7 Bn by 2036, growing ...
8d
A Revolutionary Device Can Cure Blindness. This Has ‘Never Been Done Before,’ Researcher Says.
Thanks to this tiny piece of tech, people with profound vision loss can now read, do cross word puzzles, and navigate public ...
An editorial published in the New England Journal of Medicine 1 referred to the Photovoltaic Retina Implant Microarray (PRIMA ...
Illumina has recently advanced its plan to divest its cancer-diagnostics unit, a move intended to ease regulatory pressure and sharpen its focus on core DNA sequencing and microarray technologies.
Infection with the pathogenic yeast fungus Candida auris (C. auris) can wreak havoc on the health of hospital patients and ...
Long before a liver tumor appears, a high-fat diet can push liver cells into a risky survival mode. That is the central ...
Vaxxas Pty Ltd today announced the appointment of global biopharmaceutical executive Mr David Peacock as Chief Executive ...
Understanding the genetic mechanisms linking genome variations, such as single-nucleotide polymorphisms (SNPs), to phenotypes ...
Vaxxas has appointed former Merck Global Vaccines president David Peacock as chief executive officer (CEO), marking a step in ...
Brisbane-based Vaxxas has appointed David Peacock to lead the push to bring its vaccine patch technology to market.
SHERLOCK, a rapid CRISPR-based diagnostic, detects Candida auris and antifungal resistance mutations in patient samples in under an hour.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback